Enliven Therapeutics, Inc.
US ˙ NasdaqGS ˙ US29337E1029

SecurityELVN / Enliven Therapeutics, Inc.
InsiderJoseph P Lyssikatos
This page shows the track record and history of Lyssikatos Joseph P insider trades in Enliven Therapeutics, Inc.. The SEC defines Insiders as officers, directors, or significant investors (greater than 10% ownership) in a company. It is illegal for insiders to make trades in their companies based on material, non-public information ("MNPI"). This does not mean it is illegal for them to make any trades in their own companies. However, they must report all trades to the SEC via a Form 4.
Insider Purchases - Short Term Profit Analysis

In this section, we analyze the profitability of every unplanned, open-market insider purchase made by Joseph P Lyssikatos in ELVN / Enliven Therapeutics, Inc.. This analysis helps to understand if the insider consistently generates abnormal returns, and is worth following. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Max
Price at
Max
Max
Profit ($)
Max Return (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ELVN / Enliven Therapeutics, Inc. Insider Trades
Insider Sales - Short Term Loss Analysis

In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made by Joseph P Lyssikatos in ELVN / Enliven Therapeutics, Inc.. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price. This analysis is for one-year following each trade, and the results are theoretical.

The following table shows the most recent open market purchases that were not part of an automatic trading plan.

Trade Date Reported
Shares
Reported
Price
Adjusted
Shares
Adjusted
Price
Cost Basis Days to
Min
Price at
Min
Max Loss
Avoided ($)
Max Loss
Avoided (%)
There are no known unplanned open-market trades for this insider

Adjusted Price is the split-adjusted price. Adjusted Shares is the split-adjusted shares.

ELVN / Enliven Therapeutics, Inc. Insider Trades
Insider Transaction History
File
Date
Trade
Date
Form Insider Ticker Security Title Code 10b5-1 Direct Exercise
Price
Unit
Price
Units
Changed
Value
Changed (1K)
Remaining
Options
Remaining
Shares
2025-09-23 2025-09-19 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 20.0160 -2,130 -43 933,188
2025-09-23 2025-09-19 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 19.1095 -4,870 -93 935,318
2025-08-21 2025-08-21 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 20.0132 -7,500 -150 940,188
2025-08-21 2025-08-19 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 19.6235 -5,000 -98 947,688
2025-07-23 2025-07-21 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 22.8954 -576 -13 952,688
2025-07-23 2025-07-21 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 22.2625 -11,924 -265 953,264
2025-06-24 2025-06-20 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 21.3966 -12,500 -267 965,188
2025-06-05 2025-06-03 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 20.0293 -7,500 -150 977,688
2025-05-21 2025-05-19 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 16.3067 -5,000 -82 985,188
2025-05-05 2025-05-02 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 20.0099 -2,470 -49 990,188
2025-05-05 2025-05-01 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 20.0728 -5,030 -101 992,658
2025-04-23 2025-04-21 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 16.7208 -330 -6 997,688
2025-04-23 2025-04-21 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 16.0274 -4,670 -75 998,018
2025-03-21 2025-03-19 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 20.6060 -12,500 -258 1,002,688
2024-10-22 2024-10-18 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 30.0030 -847 -25 1,015,188
2024-10-10 2024-10-09 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 28.5199 -3,589 -102 1,016,035
2024-10-10 2024-10-09 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 28.1199 -34,289 -964 1,019,624
2024-10-10 2024-10-08 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 28.5100 -100 -3 1,053,913
2024-10-10 2024-10-08 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 27.9618 -13,167 -368 1,054,013
2024-10-08 2024-10-07 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 27.6051 -2,707 -75 1,067,180
2024-10-08 2024-10-04 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 27.5109 -7,522 -207 1,069,887
2024-10-03 2024-10-01 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 27.5372 -527 -15 1,077,409
2024-09-03 2024-08-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 23.0800 -50 -1 1,077,936
2024-09-03 2024-08-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 22.4843 -11,950 -269 1,077,986
2024-08-02 2024-07-31 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 27.5571 -3,099 -85 1,089,936
2024-07-31 2024-07-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 27.4333 -203 -6 1,093,035
2024-07-31 2024-07-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 26.6855 -11,797 -315 1,093,238
2024-07-03 2024-07-01 4 Lyssikatos Joseph P ELVN Common Stock S - Sale I 22.8947 -12,000 -275 1,105,035
2024-05-31 2024-05-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 22.5212 -2,123 -48 0
2024-05-31 2024-05-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 21.5640 -9,877 -213 2,123
2024-05-31 2024-05-29 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 12,000 13 12,000
2024-05-01 2024-04-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 18.4823 -1,013 -19 0
2024-05-01 2024-04-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 17.8634 -10,987 -196 1,013
2024-05-01 2024-04-29 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 12,000 13 12,000
2024-04-15 2024-04-11 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 25.0444 -30,000 -751 0
2024-04-15 2024-04-11 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 30,000 34 30,000
2024-04-03 2024-04-01 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 19.3578 -71 -1 0
2024-04-03 2024-04-01 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 18.8038 -9,577 -180 71
2024-04-03 2024-04-01 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 17.7242 -2,352 -42 9,648
2024-04-03 2024-04-01 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 12,000 13 12,000
2024-03-04 2024-02-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 17.0938 -1,805 -31 0
2024-03-04 2024-02-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 16.2974 -10,195 -166 1,805
2024-03-04 2024-02-29 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 12,000 13 12,000
2024-01-31 2024-01-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 15.8547 -12,000 -190 0
2024-01-31 2024-01-29 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 12,000 13 12,000
2024-01-03 2023-12-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 14.7818 -2,849 -42 0
2024-01-03 2023-12-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 14.1261 -9,151 -129 2,849
2024-01-03 2023-12-29 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 12,000 13 12,000
2023-12-26 2023-12-22 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 13.0660 -6,546 -86 0
2023-12-26 2023-12-22 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 6,546 7 6,546
2023-12-26 2023-12-21 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 13.0000 -20 -0 0
2023-12-26 2023-12-21 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 20 0 20
2023-12-21 2023-12-20 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 13.0117 -8,688 -113 0
2023-12-21 2023-12-20 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 8,688 10 8,688
2023-12-21 2023-12-19 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 13.0000 -200 -3 0
2023-12-21 2023-12-19 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 200 0 200
2023-11-06 2023-11-03 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 13.0764 -8,546 -112 0
2023-11-06 2023-11-03 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 8,546 10 8,546
2023-10-03 2023-09-29 4 Lyssikatos Joseph P ELVN Common Stock S - Sale D 13.6248 -12,000 -163 0
2023-10-03 2023-09-29 4 Lyssikatos Joseph P ELVN Common Stock M - Exercise D 1.1200 12,000 13 12,000
2023-02-27 2023-02-23 4 Lyssikatos Joseph P ELVN Common Stock A - Award I 1,117,035 1,117,035
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)